Abstract | PURPOSE OF REVIEW: RECENT FINDINGS: SUMMARY:
|
Authors | Eric Jacobsen, Arnold Freedman |
Journal | Current opinion in oncology
(Curr Opin Oncol)
Vol. 16
Issue 2
Pg. 106-13
(Mar 2004)
ISSN: 1040-8746 [Print] United States |
PMID | 15075900
(Publication Type: Journal Article, Review)
|
Chemical References |
- Antibodies, Monoclonal
- Antibodies, Monoclonal, Humanized
- Antibodies, Monoclonal, Murine-Derived
- Antibodies, Neoplasm
- Antineoplastic Agents
- Cytarabine
- Alemtuzumab
- Rituximab
- Vincristine
- Dexamethasone
- Doxorubicin
- Cyclophosphamide
- Cisplatin
- Prednisone
|
Topics |
- Alemtuzumab
- Antibodies, Monoclonal
(administration & dosage, adverse effects)
- Antibodies, Monoclonal, Humanized
- Antibodies, Monoclonal, Murine-Derived
- Antibodies, Neoplasm
(administration & dosage, adverse effects)
- Antineoplastic Agents
(administration & dosage)
- Antineoplastic Combined Chemotherapy Protocols
(administration & dosage, adverse effects, therapeutic use)
- Bone Marrow Purging
(adverse effects, methods)
- Cisplatin
(administration & dosage, adverse effects)
- Combined Modality Therapy
- Cyclophosphamide
(administration & dosage, adverse effects)
- Cytarabine
(administration & dosage, adverse effects)
- Dexamethasone
(administration & dosage, adverse effects)
- Doxorubicin
(administration & dosage, adverse effects)
- Humans
- Lymphoma, Mantle-Cell
(drug therapy, mortality, therapy)
- Prednisone
(administration & dosage, adverse effects)
- Radioimmunotherapy
- Remission Induction
- Rituximab
- Stem Cell Transplantation
(methods)
- Survival Analysis
- Transplantation, Autologous
(methods)
- Transplantation, Homologous
(methods)
- Vincristine
(administration & dosage, adverse effects)
|